This inventor holds 5 USPTO granted patents and 4 published patent applications. Top assignee: Interpace Diagnostics Corporation. Active years: 2016-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2025
Title: Innovator Extraordinaire - Eric Matthew Gayle Ellsworth
Introduction
Eric Matthew Gayle Ellsworth is a notable inventor based in Pittsburgh, PA, USA. With a remarkable portfolio consisting of five patents, Ellsworth has made significant contributions in the field of medical advancements. His work focuses on innovative methods for treating critical health conditions, earning him recognition in the medical research community.
Latest Patents
Ellsworth's most recent patents include groundbreaking techniques aimed at treating Barrett's metaplasia and esophageal adenocarcinoma. These patents disclose methods for treating Barrett's metaplasia as well as esophageal adenocarcinoma, focusing on identifying a mutational load to predict disease progression risks. Additionally, he has developed methods for accurately measuring carcinoembryonic antigen in biological samples, which also entails identifying and treating mucinous cysts in patients.
Career Highlights
Eric Matthew Gayle Ellsworth works at Interpace Diagnostics Corporation, a leading entity in the diagnostic industry. Throughout his career, he has demonstrated a commitment to advancing healthcare through his innovative inventions that address critical medical challenges.
Collaborations
Working alongside talented colleagues such as Sydney David Finkelstein and Sara Ann Jackson, Ellsworth has fostered a collaborative environment that encourages the exchange of ideas and the development of pioneering solutions in diagnostics and treatment methodologies.
Conclusion
With five patents to his name and ongoing contributions to medical research, Eric Matthew Gayle Ellsworth stands out as an influential figure in his field. His latest innovations not only push the boundaries of medical science but also enhance the quality of patient care, reaffirming his commitment to improving health outcomes and advancing medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile